Syros Pharmaceuticals (SYRS) Q3 2025 Earnings

31JulConfirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-0.68
-0.5
-0.33
-0.16

Details

Expected EPS
-0.2374
Actual EPS
N/A
Surprise EPS
0.24
Surprise Percent
+100%

Description

Syros Pharmaceuticals (SYRS) will report earnings of for Q3 2025 on July 31, 2025.

0 Comments

Share your thoughts